MT focuses on the development of disruptive imaging technologies to address the unmet clinical need in cancer imaging and management and to improve the healthcare of cancer patients. Innovative concepts and approaches are employed in the development of new products based on the understanding of advanced scientific discoveries.
By technologies and innovations, Our goals are to develop and commercialize disruptive diagnostics and therapeutics for precision cancer management in clinical practice.
Board of Management
The MT Board of Management is committed to serving the interests of the entire enterprise and achieving a sustained increase in corporate value.